Program comparison
Program Juvelook vs Program Rejuran
Start with your skin concern, not the skin-booster label
For fine lines and texture, the cited Juvelook protocol used additional HA; the cited Rejuran trial examined hydration and texture around the eyes. They cannot be compared by the skin-booster label alone. Evidence of smoother texture does not establish filling deep hollows or lifting sagging skin.
Program comparison
- Juvelook 50 mg
- PDLLA + HA
- Base Rejuran
- PN
- Separate variants
- Juvelook and Volume differ in size
- Compare price units
- cc, vial and box are not interchangeable
- Skin booster does not identify one shared formula
- Rejuran HB plus differs from the base Rejuran formula
- Milligrams are neither cubic centimetres nor a result score
- Compare the variant, amount per visit and visits included
01
Do you want smoother texture or a change in facial contour?
Separate uneven texture and fine lines from deep hollows or sagging. The evidence compared here helps explain skin-texture changes; it does not establish correction of deep acne scars or a lifting result.
For fine lines and texture, changes were reported with a protocol combining Juvelook and additional HA. The cited Rejuran trial focused on hydration and texture around the eyes. Read the comparison by concern and area, rather than assuming that the skin-booster label answers both.
| Compare skin goals and the time involved | Program Juvelook | Program Rejuran |
|---|---|---|
| Skin concerns covered by the evidence here | Fine lines and texture — studied using Juvelook with additional HA, not Juvelook alone. | Hydration and texture around the eyes — not evidence of whole-face hollow correction. |
| How many visits were involved?* | 2–3 sessions, 4 weeks apart | 3 sessions, 2 weeks apart |
| When were outcomes assessed?* | Follow-up 12–16 weeks after the final session | Overall assessment at weeks 10, 16 and 28 from the first session |
| What recovery effects were reported? | Procedural pain and redness were reported; no universal recovery deadline established. | Redness, itching and irritation were reported; not a promise of mark-free skin before an event. |
*Visits and follow-up dates come from research, not clinic packages or promised onset. Neither study directly compared Juvelook with Rejuran. Individual results vary.
02
How do their formulas differ?
Juvelook combines PDLLA and HA; base Rejuran lists PN. They are different formulas even when both are described as skin boosters.
Juvelook and Rejuran HB plus both list an HA component, but the rest of their formulas differ. That shared component does not establish that they can be substituted, produce the same result or suit the same treatment area.
03
How do Juvelook Volume and Rejuran HB plus differ from the base variants?
The manufacturer lists Juvelook at 50 mg and Volume at 200 mg. These figures describe ingredient mass, not injection volume, and do not establish a proportional increase in results.
Rejuran HB plus includes sodium hyaluronate and lidocaine hydrochloride alongside sodium polynucleotide. The manufacturer lists 1 mL per syringe, so keep this variant separate when comparing ingredients and quantities.
04
Can a price per cc be compared directly with a price per box?
Not without the contents and treatment quantity. A cc price describes volume; a vial or box price needs its contents and the amount supplied per visit. A smaller headline price does not establish a lower total treatment cost.
Compare the exact variant, amount per visit, number of visits and included fees before comparing plan totals. Do not divide Juvelook milligrams by Rejuran cubic centimetres: they measure different things.
05
FAQ
Are Juvelook and Rejuran the same ingredient?
No. Juvelook 50 mg lists PDLLA with HA, while base Rejuran lists PN. Separate the formulas first; the skin-booster label does not establish interchangeability.
Are all Rejuran variants identical?
No. HB plus, for example, lists sodium hyaluronate and lidocaine hydrochloride alongside sodium polynucleotide. Base-formula descriptions should not be applied to every variant.
Can I choose between Juvelook 50 mg and Volume 200 mg by the number?
The number describes ingredient mass, not a result score or injection volume. Milligrams alone cannot determine suitability or a session count.
How do I compare a cc price with a vial price?
First match the variant, amount supplied per visit, number of visits and included charges. Vials, boxes and cc cannot be treated as equivalent units without their packaging details.
Will results appear as soon as the listed sessions are completed?
The table gives study assessment dates, not guaranteed onset or an identical result for everyone. Allow for both intervals between visits and assessment after the final session; a same-day photograph cannot establish the later outcome.
Can Juvelook and Rejuran be performed together?
These two studies do not answer same-day use of this pair. The Juvelook protocol added HA, not Rejuran; the Rejuran trial used HA on the opposite side, not combined with Juvelook. Neither establishes same-day compatibility or a required interval for this combination.
06
About the comparison evidence
The Juvelook evidence comes from 16 Korean participants treated with additional HA and lidocaine, without a control group. The Rejuran study treated 27 women around the eyes, comparing PN with HA on opposite sides of the face, not with Juvelook.
Both studies received manufacturer funding. They describe observations within their respective protocols, not a ranking of results, a fixed recovery deadline or same-day use of Juvelook and Rejuran.
Evidence notes
Seo SB, Park H, Jo JY, Ryu HJ.
Skin rejuvenation effect of the combined PDLLA and non cross-linked hyaluronic acid: A preliminary study
Journal of Cosmetic Dermatology
Lee et al.
Comparison of the effects of polynucleotide and hyaluronic acid fillers on periocular rejuvenation: a randomized, double-blind, split-face trial
Journal of Dermatological Treatment